Answers are grounded in this paper and cite their sources.
Background Accurate assessment of cervical lesion severity is crucial for precise diagnosis and timely clinical decision-making. DNA methylation, which can be readily detected using molecular methods, has emerged as a promising approach for identifying biomarkers for cervical cancer screening and triage. However, previous studies primarily reported binary positive/negative rates without characterizing the continuous quantitative spectrum of ΔCp changes across lesion grades. This study aimed to evaluate the ΔCp values of six markers (ASTN1, DLX1, ITGA4, RXFP3, SOX17, and ZNF671) for cross-sectional discrimination of cervical lesion severity. Methods We used quantitative methylation-specific polymerase chain reaction (qMSP) to measure the methylation levels of the six markers in cervical scrapes. The results were expressed as ΔCp values (Cp target – Cp reference), with ACHE serving as the reference gene for normalization. The study cohort comprised 14 cases of cervical cancer (CC), 23 cases of CIN3, 53 cases of CIN2, 115 cases of CIN1, and 55 normal cases. All patients underwent HPV testing, ThinPrep cytological testing (TCT), colposcopic biopsy, and DNA methylation analysis. ΔCp values of ASTN1, DLX1, ITGA4, RXFP3, SOX17, and ZNF671 generally decreased across histological grades from normal tissue to CIN1, CIN2, CIN3, and cervical cancer. Results These markers exhibited superior performance in detecting CIN2+ and in cross-sectional discrimination of invasive cancer within the CIN2+ subgroup. For differentiating CIN1- from CIN2+, AUCs for the six individual methylation markers ranged from 0.707 to 0.816 using 1,000 bootstrap resamples for 95% confidence intervals. These values were higher than those observed for TCT (AUC = 0.554), Other HPV only (AUC = 0.354), and HPV16/18 testing (AUC = 0.653). Among the six markers, ZNF671 demonstrated the highest diagnostic accuracy for detecting CIN2+ (AUC = 0.816, 95% CI: 0.763-0.867). In the CIN2+ subgroup, marker AUCs for distinguishing invasive cancer from CIN2/3 ranged from 0.804 to 0.854. Conclusions Quantitative DNA methylation profiling of the predefined six-gene panel provides information for cross-sectional discrimination of cervical lesion severity in cervical scrape samples, with ZNF671 showing the strongest single-marker performance in this cohort.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: